Schedule-dependent paclitaxel tolerance/activity: data from a 7 day infusion phase I study with pharmacokinetics in paclitaxel refractory ovarian cancer
Souli??, P, Trandafir, L, Taamma, A, Lokiec, F, Brain, E, Delord, JP, Mita, A, Vannetzel, JM, Cvitkovic, E, Misset, JLVolume:
8
Journal:
Anti-Cancer Drugs
DOI:
10.1097/00001813-199709000-00005
Date:
September, 1997
File:
PDF, 294 KB
1997